×
Back to Agenda
Oncology Pathways Under Pressure: From CAR-T Access Today to Longevity-Driven Care Tomorrow
Session Chair(s)
Bradley Watts
Vice President, Business Development Executive
Connor, Strong, and Buckelew, United States
By placing CAR-T within a broader trajectory—from breakthrough therapies today to longevity-driven oncology tomorrow—this session challenges stakeholders to rethink how access, value, and sustainability must evolve to keep pace with scientific progress.
Learning Objective : Assess how CAR-T experience has revealed gaps in health technology assessment and reimbursement in the US and Europe; Examine how durable benefit, earlier intervention, and longer oncology horizons challenge current value, outcomes, and sustainability models; Apply multi-stakeholder and patient insights to inform evolving reimbursement and access approaches for potentially curative therapies.
Speaker(s)
Panelist
Ronald DePinho, MD
The University of Texas MD Anderson Cancer Center, United States
Professor, Cancer Biology
Panelist
Laura Okpala, MPH
Gilead Sciences, United States
Executive Director, Head of US Reimbursement Policy
Panelist
Tom Whitehead
Emily Whitehead Foundation, United States
Co-Founder and President
Have an account?